It has been about a month since the last earnings report for Ford Motor Company (F) . Shares have added about 6.6% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Ford Motor due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Ford Q3 Earnings Match Estimates Ford repo ...

A month has gone by since the last earnings report for UFP Industries (UFPI) . Shares have added about 11.8% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is UFP Industries due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. UFP Industries Q3 Earnings & Sales Miss Estima ...

It has been about a month since the last earnings report for Waste Management (WM) . Shares have added about 3.8% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Waste Management due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Waste Management Beats Q3 Earnings Es ...

Shares of Sarepta Therapeutics (SRPT) rose nearly 14% on Tuesday after announcing that it has entered into an exclusive global licensing and collaboration agreement with Arrowhead Pharmaceuticals .ARWR Deal Expands Sarepta’s PipelinePer the deal terms, Sarepta will acquire exclusive rights to Arrowhead’s seven pipeline programs, which include four in active clinical development and the remaining three in preclinical development. These programs are being developed against a broad range of genetic diseases in ...

Ambarella (AMBA 4.44%) stock soared nearly 19% Wednesday morning after reporting a strong earnings beat last night. The stock has since given back about half its gains, but as of 11:20 a.m. ET is still up 7.7%.Analysts had forecast Ambarella to earn $0.04 per share on $79 million in sales. In fact, the company reported Q3 earnings of $0.11 per share, and sales of $82.6 million. Adding to the good news, Ambarella raised guidance for Q4 sales. Ambarella Q3 earnings reflect AI gainsOnce upon a time, Ambarella ...

TransMedics Group (TMDX) is a key player in transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The company offers Organ Care System, an integrated, compact, portable preservation technology that addresses unmet need for organs for transplantation. However, with a forward 12-month price-to-sales (P/E) ratio of 5.02X — above the Zacks Medical - Instruments industry average of 4.44X — there are concerns about the justification of TransMedics’ premium valuation in t ...

Lockheed Martin Corp. (LMT) recently revealed that it has completed testing for its LM 400 space vehicle and is progressing toward its imminent launch. With the company steadily investing in its technology demonstrations, this space vehicle is expected to embark on its journey in the first half of 2025. Impressively, LM 400 offers greater propulsion and better low-earth orbit (LEO), medium-earth orbit (MEO) and geosynchronous equatorial orbit (GEO) operability than others in its class. The recent news refle ...

Exelixis, Inc. (EXEL) announced that its supplemental new drug application (sNDA) for cabozantinib will be discussed at an Oncologic Drugs Advisory Committee (“ODAC”) meeting in March 2025.The sNDA is seeking approval for the drug to treat adults with previously treated advanced pancreatic neuroendocrine tumors (pNET) and advanced extra-pancreatic NET (epNET).Exelixis’ shares have surged 48.9% year to date against the industry’s decline of 7.8%.Image Source: Zacks Investment ResearchDetails of EXEL’s sNDA f ...

The Boeing Company (BA) recently secured a modification contract to remanufacture Block I CH-47F Chinook helicopter into Block II. The award is expected to be completed by Dec. 31, 2026. Valued at $113.1 million, the contract has been provided by the Army Contracting Command, Redstone Arsenal, AL.What’s Favoring Boeing?As nations across the globe continue to strengthen their defense structures, spending on military arms and ammunition that boast technologically advanced features continues to increase manifo ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...